It is estimated that50% of all cancers develop due to mutations in p53 [21]–[23].Therefore, we first tested the effect of AECHL-1 cytotoxicity and proliferation infour different cancerous cell lines with different tissue origin that contain eitherwild-type or mutant p53, as well as p53 null. This evidence concerns the gene TP53 and cancer.